Multiply Labs, Inc. has successfully completed a private offering, raising a total of $52,250,260. This significant funding achievement highlights the company’s growth potential and investor confidence in its future.

The offering was filed with the SEC on November 5, 2026, under the submission type D. The filing indicates that the offering was fully subscribed, with no remaining amounts left. This reflects a strong interest from investors, with a total of 22 investors participating in the offering.

Company Background

Multiply Labs, Inc. is a corporation incorporated in Delaware. The company is based in San Francisco, California, and operates within the technology sector. It was previously known as Pharmacube, Inc. The company has been active in filing with the SEC, with its most recent filings including a Form D on April 24, 2023, and another on April 21, 2021.

What the Filing Says

The SEC filing states that the offering was made under Rule 506(b), which provides a safe harbor for private offerings. The total offering amount was $52,250,260, which has already been fully sold, indicating strong demand from accredited investors.

Impact

This successful fundraising round may have significant implications for Multiply Labs and its stakeholders. The funds raised could be used for various purposes, including expansion, product development, or operational enhancements. Additionally, this success may prompt competitors in the technology sector to evaluate their own funding strategies and market positioning.

What's Next

The filing does not say what happens next.